Aridol has already been approved in Europe by the mutual recognition procedure and is now awaiting confirmation of national approval in Portugal. Claimed to be a simple-to-use airways inflammation test, Aridol is administered as a dry powder in a hand-held inhaler.
Ricardo Villar, president of Pulmocor, said: “Founded in 1982, Pulmocor has a strong reputation for quality and excellence among respiratory specialists and brings many years of bronchial challenge testing experience to the promotion of Aridol. Pulmocor is currently extending its activity into specialist pharmaceutical products and Aridol represents an important addition to our portfolio and our ability to service respiratory specialists.”